Financial
Latest full-year results from official filings.
FY2025 revenue $311.1m (+1.5%); operating margin -51.7%; net loss $178.0m.
Cash $95.7m; debt $153.3m.
- Official results release · Health Catalyst · 31 Dec 2025
Health Catalyst: risk summary
Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Adverse media
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Aug 2025: Health Catalyst said long-time CEO Dan Burton would step down; Benjamin Albert is now CEO. Jul 2026: it sold its Vitalware business to Med-Metrix for $147m and used the proceeds to repay about $160m of debt.
- Health Catalyst announces CEO Dan Burton to step down · Health Catalyst · 7 Aug 2025
- Health Catalyst closes sale of Vitalware to Med-Metrix · HIT Consultant · 6 Aug 2026
- Health Catalyst (HCAT) Q2 2026 earnings call transcript · The Motley Fool · 13 Aug 2026
Cyber & information governance
Data breaches, cyber incidents, regulator action and assurance status.
No data breaches, cyber incidents or regulator action involving Health Catalyst found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Regulatory & clinical safety
Recalls, safety notices, regulator action and clinical safety concerns.
Healthcare data and analytics software supplier; no regulatory or clinical safety actions found in the last 24 months.
Contract performance
Contract delivery, go-lives, terminations and disputes.
No notable contract disputes, terminations or troubled implementations involving Health Catalyst found in HSH's search of the last 24 months.